Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Diseasesort descending Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Age-related macular degeneration iPS Cell Exploring disease mechanisms UCSD
Research Insights
Age-related macular degeneration Embryonic Stem Cell Donor cell therapy USC
Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration iPS Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
Alpha Thalassemia Major Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Alzheimer's Disease Embryonic Stem Cell,
iPS Cell
Small molecule therapy Salk
Pre-IND/IDE or Equivalent
Alzheimer's Disease Embryonic Stem Cell Exosomes based therapy UC Irvine
Proof of Concept, Research Insights
Alzheimer's Disease Embryonic Stem Cell Specific Cell Type Derivation UC Irvine
Development Candidate, Tool/Resources/Bottleneck
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, personalized cell therapy BrainStorm
Clinical Trial, Phase 3
Amyotrophic Lateral Sclerosis,
Spinal Cord Injury
Embryonic Stem Cell,
iPS Cell
Cell imaging & tracking UCSD
Research Insights
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Amyotrophic Lateral Sclerosis,
Spinal Cord Injury,
Spinal Muscular Atrophy
Embryonic Stem Cell Model system development UCLA
Tool/Resources/Bottleneck
Arthritis,
Osteoarthritis
Adult Stem Cell Small molecule therapy Calibr
Clinical Trial, Phase 1 or Phase 1/2
Autism Adult Stem Cell Gene-modified, donor cell therapy UC Davis
Development Candidate, Proof of Concept
Autism iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
B cell cancers,
Leukemia
Cancer Stem Cell Antibody COH
Development Candidate, Proof of Concept
B cell cancers,
Leukemia
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
B cell cancers,
Leukemia
Cancer Stem Cell Antibody UCSD
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia Adult Stem Cell Gene-modified, personalized cell therapy Sangamo
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test CHORI
Regulated Lab Test, Ready for Validation
Bladder or Urinary Tract Disorder,
Solid Tumors
Embryonic Stem Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Blood Disorders Embryonic Stem Cell Specific Cell Type Derivation UCLA
Tool/Resources/Bottleneck
Blood Disorders,
Blood Cancer
Adult Stem Cell Small molecule therapy UCLA
Development Candidate
Blood Disorders Embryonic Stem Cell Donor cell therapy UCSF
Research Insights
Blood Disorders Adult Stem Cell Exploring stem cell mechanisms UCLA
Development Candidate, Proof of Concept, Research Insights
Blood Disorders Adult Stem Cell Cell processing & handling Stanford
Research Insights
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Blood Disorders iPS Cell Model system development Stanford
Research Insights, Tool/Resources/Bottleneck
Blood Disorders Adult Stem Cell Cell processing & handling UCSF
Tool/Resources/Bottleneck
Blood Disorders,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Blood Cancer,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Donor cell therapy CHLA
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer,
Ovarian Cancer
iPS Cell Donor cell therapy UCSD
Development Candidate
Blood Cancer Adult Stem Cell Donor cell therapy Angiocrine
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease iPS Cell Donor cell therapy Cedars-Sinai
Proof of Concept, Research Insights
Bone or Cartilage Disease Adult Stem Cell Donor cell therapy UCLA
Proof of Concept
Bone or Cartilage Disease Embryonic Stem Cell Donor cell therapy Scripps Health
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Adult Stem Cell Cell imaging & tracking UC Davis
Tool/Resources/Bottleneck
Bone or Cartilage Disease Adult Stem Cell Tissue engineering Stanford
Proof of Concept, Research Insights
Bone or Cartilage Disease Embryonic Stem Cell Donor cell therapy USC
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Adult Stem Cell Small molecule therapy MAX BioPharma, Inc.
Pre-IND/IDE or Equivalent
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
IND
Brain Cancer Cancer Stem Cell Vaccine Stanford
Pre-IND/IDE or Equivalent
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Canavan Disease iPS Cell Gene-modified, personalized cell therapy COH
Pre-IND/IDE or Equivalent
Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Cancer Cancer Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Cancer Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Cancer Embryonic Stem Cell Donor cell therapy UCLA
Tool/Resources/Bottleneck

Pages

Icon for csv export